Dr. Dalgleish was appointed to the Foundation Chair in Oncology at St. George’s University of London in 1991, where his main interest has been the immunology of cancer and the development of immunotherapies to treat, in particular, melanoma. He is a co-founder of Onyvax, a company set up in 1998 to make novel vaccines for common solid tumors, where he is currently interested in the development of therapeutic cancer vaccines.
In addition to basic clinical work Dr. Dalgleish has been involved in trials with vaccines for melanoma, prostate and pancreatic cancer. Current focus is the interaction of other modalities, such as radiotherapy and chemotherapy, with these vaccines. Dr. Dalgleish studied medicine at University College London where he obtained an MBBS and a BSc in anatomy. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists.
Dr. Dalgleish also trained in Internal Medicine and Oncology in Brisbane and Sydney. Following an interest in how viruses caused cancer, he commenced an MD with Professor Robin Weiss, FRS at the Institute of Cancer Research and Royal Marsden Hospital. He then followed five years as a clinical scientist at the MRC’s clinical research center in Northwick Park. Dr. Delgleish has published over 300 peer-reviewed papers, co-edited 5 textbooks. He serves on numerous boards and grant committees, including AMRF (U.S.A), Genome Canada, EU Framework, and ongoing research programs in Belgium and Austria,. He also served as a visiting examiner, Nottingham University and an external lecturer, Karolinska Institute.
Dr. Herndon earned her Bachelors Degrees in Economics and Political Science, as well as a Masters and a PhD in International Law and Economics from Johns Hopkins University. Subsequently, she worked for the U.S. Department of Agriculture as an economist, then joined the State Department and was posted to U.S. Embassy Commerce positions in Africa and Europe.
Upon leaving the State Department, Dr. Herndon founded and continues to direct GB Herndon and Associates, which is domiciled in the District of Columbia. The company initially focused upon structuring medical and benefits insurance for its corporate clients, but evolved into a multi-line insurance broker and is now more than a decade old. Its diverse clientele include the National Medical Association, embassies of foreign governments, the National Association of Postal and Federal Employees (NAPFE) and the University of the District of Columbia.
In recent years, Dr. Herndon has further diversified the company by forging strategic partnerships with leading providers of insurance and student financial services for the higher education market. GB Herndon and Associates maintains corporate affiliations with National Association for Equal Opportunity in Higher Education (NAFEO), the American Association of Community Colleges (AACC), and the Association of Community College Trustees (ACCT).
Dr. Herndon is active in the business and local communities through her active involvement with various organizations such as the Board of Trade, the DC Chamber of Commerce, the National Conference of Negro Women (NCNW), Africare, and Women’s Business Network, to name a few. Corporations including Office Depot, Six Continent Hotels, and American Express have appointed her to Advisory Board positions. Dr. Herndon co-chairs the Board of Directors of the Women’s Business Center and chairs the Corporate Advisory Boards of the National Head Start Association (NHSA) and the National Association for Equal Opportunity in Higher Education (NAFEO). On occasion, she is a consulting resource for the National Institutes of Health (NIH) regarding the impact of the HIV/AIDS pandemic on the insurance industry and provides other AIDS-related information when requested by the United States Department of State.
Dr. Herndon is a published author, member of numerous public and private entity boards and the recipient of a number of awards. She also established the Small Business Administration’s (SBA) program for advising small and minority-owned businesses on the design and implementation of business and benefits insurance programs.
Dr. Ndiouga Dieng is currently Senior Pharmacy Manger of John Hopkins Hospital since 2007 he manages the evening and overnight hospital operations and staff, Supervises the preparation of admixtures including Investigational Medications. Provided rapport to International Patients, Directed an Overseas Pathologist Project between John Hopkins and Senegal Directed an Overseas Vaccination Project between John Hopkins, Serum Institute of India and Senegal. Dr. Dieng is a graduate of Howard University.